Dr Humphreys discusses biosimilar copay programs.
Sophia Humphreys, PharmD, MHA
Advertisement
Articles by Sophia Humphreys, PharmD, MHA
Dr Humphreys discusses pharmacy and provider collaboration.
Dr Humphreys discusses key factors to consider when switching to biosimilars.
Dr Humphreys gives advice for states that require prior prescriber approval for substitution.
Dr. Humphreys discusses operationalizing biosimilars in specialty pharmacies.
Sophia Humphreys, PharmD, MHA, BCBBS, discusses biosimilar utilization and inventory management.
Sophia Humphreys, PharmD, MHA, BCBBS, discusses the key differences between biologics and biosimilars.
The PSJH COVID Workgroup was formed after the concept arose out of the early work of physicians and pharmacists at PSJH.
Advertisement
Latest Updated Articles
Pharmacy and Provider CollaborationPublished: September 6th 2024 | Updated:
- Operationalizing Biosimilars in Specialty Pharmacies
Published: August 30th 2024 | Updated:
Summary of the PSJH System Pharmacy Clinical Service COVID-19 ResponsePublished: May 3rd 2021 | Updated:
- Advice for States that Require Prior Prescriber Approval for Substitution
Published: August 30th 2024 | Updated:
- Key Factors to Consider when Switching to Biosimilars
Published: September 6th 2024 | Updated:
- Biosimilar Copay Programs
Published: September 13th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
2
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
3
A Multifaceted Approach to Navigating Career Transitions in Pharmacy
4
First FDA-Approved Oral Liquid Sitagliptin for Adults with Type 2 Diabetes
5
